R
66
-4
MUR
50
-2
MTCH
44
-4
MDLZ
65
-2
MAT
51
-3
PNW
66
3
NKE
46
12
BWA
45
-4
BAX
30
-3
HCP
64
-2
KEY
51
-3
XRX
52
-3
TDC
59
10
EXPD
53
-3
SCHW
52
3
FLS
56
-3
ILMN
41
-3
DUK
64
2
BRK.B
42
-3
BMY
56
3
R
66
-4
MUR
50
-2
MTCH
44
-4
MDLZ
65
-2
MAT
51
-3
PNW
66
3
NKE
46
12
BWA
45
-4
BAX
30
-3
HCP
64
-2
KEY
51
-3
XRX
52
-3
TDC
59
10
EXPD
53
-3
SCHW
52
3
FLS
56
-3
ILMN
41
-3
DUK
64
2
BRK.B
42
-3
BMY
56
3
Financhill
Back

Nuveen New York Quality Municipal Income Fund Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
44

NAN
Nuveen New York Quality Municipal Income Fund

Last Price:
11.74
Seasonality Move:
-2.7%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
44
Nuveen New York Quality Municipal Income Fund (NAN) is a Sell

Is Nuveen New York Quality Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen New York Quality Municipal Income Fund [NAN] share price is $11.74. The Score for NAN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • NAN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NAN Stock Price Chart

What is Nuveen New York Quality Municipal Income Fund's stock price today?

  • The Nuveen New York Quality Municipal Income Fund share price today is $11.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAN is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

NAN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 72.93 Buy
Chaikin Money Flow: 63418 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.47 - 11.65) Buy
Bollinger Bands (100): (10.92 - 11.54) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

NAN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.68 Buy
20-day SMA: 11.58 Buy
50-day SMA: 11.47 Buy
200-day SMA: 11.06 Buy
8-day EMA: 11.67 Buy
20-day EMA: 11.6 Buy
50-day EMA: 11.47 Buy
200-day EMA: 11.08 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Nuveen New York Quality Municipal Income Fund Earnings Growth & NAN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Nuveen New York Quality Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):